Transfusion Associated HCV in a Pediatric Population
2 other identifiers
observational
N/A
0 countries
N/A
Brief Summary
To identify a large cohort of children transfused in the decade prior to second-generation anti-hepatitis C virus (HCV) donor screening (1982-1992). This will not only identify cases for the study of persistent infection and chronic hepatitis in children, but will allow for the determination of the annualized risk of transfusion-associated hepatitis (TAH) infection in children, data that are not currently available.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started May 1996
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 1996
CompletedFirst Submitted
Initial submission to the registry
May 25, 2000
CompletedFirst Posted
Study publicly available on registry
May 26, 2000
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2001
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2001
CompletedDecember 17, 2015
April 1, 2002
4.9 years
May 25, 2000
December 16, 2015
Conditions
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
- Naomi Lubanlead
- National Heart, Lung, and Blood Institute (NHLBI)collaborator
Study Design
- Study Type
- observational
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
May 25, 2000
First Posted
May 26, 2000
Study Start
May 1, 1996
Primary Completion
April 1, 2001
Study Completion
April 1, 2001
Last Updated
December 17, 2015
Record last verified: 2002-04